Recommendations for using artificial intelligence in clinical flow cytometry
Cytometry Part B: Clinical Cytometry · 2024-07 · 106 (4) · 228-238
DOI: 10.1002/cyto.b.22166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cytometry Part B: Clinical Cytometry, online erschienen am 26.02.2024. Verfasst von David P Ng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Flow Cytometry, Artificial Intelligence. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
Flow cytometry is a key clinical tool in the diagnosis of many hematologic malignancies and traditionally requires close inspection of digital data by hematopathologists with expert domain knowledge. Advances in artificial intelligence (AI) are transferable to flow cytometry and have the potential to improve efficiency and prioritization of cases, reduce errors, and highlight fundamental, previously unrecognized associations with underlying biological processes. As a multidisciplinary group of stakeholders, we review a range of critical considerations for appropriately applying AI to clinical flow cytometry, including use case identification, low and high risk use cases, validation, revalidation, computational considerations, and the present regulatory frameworks surrounding AI in clinical medicine. In particular, we provide practical guidance for the development, implementation, and suggestions for potential regulation of AI‐based methods in the clinical flow cytometry laboratory. We expect these recommendations to be a helpful initial framework of reference, which will also require additional updates as the field matures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
- Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
- Department of Preclinical Development and Validation, Fraunhofer Institute for Cell Therapy and Immunology, IZI, Leipzig, Germany.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- MLL Munich Leukemia Laboratory GmbH, Munich, Germany.
- BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: David P Ng, Nina Rolf, Kamila Czechowska
Zitieren
APA
Ng, D. P., Simonson, P. D., Tarnok, A., Lucas, F., Kern, W., Rolf, N., Bogdanoski, G., Green, C., Brinkman, R. R., & Czechowska, K. (2024). Recommendations for using artificial intelligence in clinical flow cytometry. Cytometry Part B: Clinical Cytometry, 106(4), 228-238. https://doi.org/10.1002/cyto.b.22166
Vancouver
Ng DP, Simonson PD, Tarnok A, Lucas F, Kern W, Rolf N, et al. Recommendations for using artificial intelligence in clinical flow cytometry. Cytometry Part B: Clinical Cytometry. 2024;106(4):228-238. doi:10.1002/cyto.b.22166
BibTeX
@article{Ng2024,
author = {Ng, David P and Simonson, Paul D and Tarnok, Attila and Lucas, Fabienne and Kern, Wolfgang and Rolf, Nina and Bogdanoski, Goce and Green, Cherie and Brinkman, Ryan R and Czechowska, Kamila},
title = {Recommendations for using artificial intelligence in clinical flow cytometry},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2024},
volume = {106},
number = {4},
pages = {228--238},
doi = {10.1002/cyto.b.22166}
}
EUVIMED